Comparison of parasite sequestration in uncomplicated and severe childhood Plasmodium falciparum malaria

Journal of Infection

Volumn 67, Issue 3, 2013, Pages 220-230

  Cunnington, Aubrey J ^a,b,c   Bretscher, Michael T ^a   Nogaro, Sarah I ^a,b   Riley, Eleanor M ^a   Walther, Michael ^b,d  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Anaemia; Cerebral malaria; HRP2; Lactic acid; Microcirculation; Parasite Biomass; Sequestration

Indexed keywords

ANTIMALARIAL AGENT; CARRIER PROTEIN; HISTIDINE RICH PROTEIN 2; LACTIC ACID; UNCLASSIFIED DRUG;

AGE; ANEMIA; ARTICLE; BRAIN MALARIA; CHILD; CLONAL VARIATION; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHROCYTE; FATALITY; FEMALE; GAMBIA; HUMAN; HYPERLACTATEMIA; LACTATE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MATHEMATICAL MODEL; MICROBIAL BIOMASS; PARASITE PHENOMENA AND FUNCTIONS; PARASITE SEQUESTRATION; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS;

ANAEMIA; CEREBRAL MALARIA; HRP2; LACTIC ACID; MICROCIRCULATION; PARASITE BIOMASS; SEQUESTRATION;

ANTIGENS, PROTOZOAN; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ERYTHROCYTES; FEMALE; HUMANS; LACTIC ACID; MALARIA, CEREBRAL; MALARIA, FALCIPARUM; MALE; MODELS, BIOLOGICAL; PARASITEMIA; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 84881028070     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2013.04.013     Document Type: Article

References (57)

1. Murray C.J., Rosenfeld L.C., Lim S.S., Andrews K.G., Foreman K.J., Haring D., et al. Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 2012, 379:413-431.
2. von Seidlein L., Olaosebikan R., Hendriksen I.C., Lee S.J., Adedoyin O.T., Agbenyega T., et al. Predicting the clinical outcome of severe falciparum malaria in african children: findings from a large randomized trial. Clin Infect Dis 2012, 54:1080-1090.
3. Hanson J., Lee S.J., Mohanty S., Faiz M.A., Anstey N.M., Charunwatthana P., et al. A simple score to predict the outcome of severe malaria in adults. Clin Infect Dis 2010, 50:679-685.
4. Dondorp A., Nosten F., Stepniewska K., Day N., White N. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 2005, 366:717-725.
5. Dondorp A.M., Fanello C.I., Hendriksen I.C., Gomes E., Seni A., Chhaganlal K.D., et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet 2010, 376:1647-1657.
6. Planche T., Krishna S. The relevance of malaria pathophysiology to strategies of clinical management. Curr Opin Infect Dis 2005, 18:369-375.
7. Maitland K. Severe malaria: lessons learned from the management of critical illness in children. Trends Parasitol 2006, 22:457-462.
8. Krishna S. Adjunctive management of malaria. Curr Opin Infect Dis 2012, 25:484-488.
9. Maitland K., Kiguli S., Opoka R.O., Engoru C., Olupot-Olupot P., Akech S.O., et al. Mortality after fluid bolus in African children with severe infection. N Engl J Med 2011, 364:2483-2495.
10. John C.C., Kutamba E., Mugarura K., Opoka R.O. Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malaria. Expert Rev Anti Infect Ther 2010, 8:997-1008.
11. Miller L.H., Ackerman H.C., Xin-zhuan S., Wellems T.E. Malaria biology and disease pathogenesis: insights for new treatments. Nat Med 2013, 19:156-167.
12. English M., Sauerwein R., Waruiru C., Mosobo M., Obiero J., Lowe B., et al. Acidosis in severe childhood malaria. QJM 1997, 90:263-270.
13. World Health Organization, Communicable Diseases Cluster Severe falciparum malaria. Trans R Soc Trop Med Hyg 2000, 94(Suppl. 1):S1-90.
14. Newton C.R., Valim C., Krishna S., Wypij D., Olola C., Agbenyega T., et al. The prognostic value of measures of acid/base balance in pediatric falciparum malaria, compared with other clinical and laboratory parameters. Clin Infect Dis 2005, 41:948-957.
15. Waller D., Krishna S., Crawley J., Miller K., Nosten F., Chapman D., et al. Clinical features and outcome of severe malaria in Gambian children. Clin Infect Dis 1995, 21:577-587.
16. Planche T., Agbenyega T., Bedu-Addo G., Ansong D., Owusu-Ofori A., Micah F., et al. A prospective comparison of malaria with other severe diseases in African children: prognosis and optimization of management. Clin Infect Dis 2003, 37:890-897.
17. Rowe J.A., Claessens A., Corrigan R.A., Arman M. Adhesion of Plasmodium falciparum-infected erythrocytes to human cells: molecular mechanisms and therapeutic implications. Expert Rev Mol Med 2009, 11:e16.
18. Dondorp A.M., Pongponratn E., White N.J. Reduced microcirculatory flow in severe falciparum malaria: pathophysiology and electron-microscopic pathology. Acta Trop 2004, 89:309-317.
19. Hanson J., Lam S., Mahanta K.C., Pattnaik R., Alam S., Mohanty S., et al. Relative contributions of macrovascular and microvascular dysfunction to disease severity in falciparum malaria. J Infect Dis 2012.
20. Silamut K., Phu N.H., Whitty C., Turner G.D., Louwrier K., Mai N.T., et al. A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain. Am J Pathol 1999, 155:395-410.
21. Taylor T.E., Fu W.J., Carr R.A., Whitten R.O., Mueller J.S., Fosiko N.G., et al. Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nat Med 2004, 10:143-145.
22. Dondorp A.M., Desakorn V., Pongtavornpinyo W., Sahassananda D., Silamut K., Chotivanich K., et al. Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2. PLoS Med 2005, 2:e204.
23. Genton B., D'Acremont V., Rare L., Baea K., Reeder J.C., Alpers M.P., et al. Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med 2008, 5:e127.
24. Anstey N.M., Douglas N.M., Poespoprodjo J.R., Price R.N. Plasmodium vivax: clinical spectrum, risk factors and pathogenesis. Adv Parasitol 2012, 80:151-201.
25. Seydel K.B., Milner D.A., Kamiza S.B., Molyneux M.E., Taylor T.E. The distribution and intensity of parasite sequestration in comatose Malawian children. J Infect Dis 2006, 194:205-208.
26. Kim H., Higgins S., Liles W.C., Kain K.C. Endothelial activation and dysregulation in malaria: a potential target for novel therapeutics. Curr Opin Hematol 2011, 18:177-185.
27. Dondorp A.M., Lee S.J., Faiz M.A., Mishra S., Price R., Tjitra E., et al. The relationship between age and the manifestations of and mortality associated with severe malaria. Clin Infect Dis 2008, 47:151-157.
28. Walther M., Jeffries D., Finney O.C., Njie M., Ebonyi A., Deininger S., et al. Distinct roles for FOXP3 and FOXP3 CD4 T cells in regulating cellular immunity to uncomplicated and severe Plasmodium falciparum malaria. PLoS Pathog 2009, 5:e1000364.
29. Smith T., Dietz K., Vounatsou P., Muller I., English M., Marsh K. Bayesian age-stage modelling of Plasmodium falciparum sequestered parasite loads in severe malaria patients. Parasitology 2004, 129:289-299.
30. Hendriksen I.C., Mwanga-Amumpaire J., von Seidlein L., Mtove G., White L.J., Olaosebikan R., et al. Diagnosing severe falciparum malaria in parasitaemic African children: a prospective evaluation of plasma PfHRP2 measurement. PLoS Med 2012, 9:e1001297.
31. Raes A., Van Aken S., Craen M., Donckerwolcke R., Vande Walle J. A reference frame for blood volume in children and adolescents. BMC Pediatr 2006, 6:3.
32. Snounou G., Viriyakosol S., Zhu X.P., Jarra W., Pinheiro L., do Rosario V.E., et al. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol Biochem Parasitol 1993, 61:315-320.
33. Edwards M.D., Morris G.A., Burr S.E., Walther M. Evaluating the frequency of bacterial co-infections in children recruited into a malaria pathogenesis study in The Gambia, West Africa using molecular methods. Mol Cell Probes 2012, 26:151-158.
34. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. JR Statist Soc B 1995, 57:289-300.
35. Craig A.G., Grau G.E., Janse C., Kazura J.W., Milner D., Barnwell J.W., et al. The role of animal models for research on severe malaria. PLoS Pathog 2012, 8:e1002401.
36. Cunnington A.J., Riley E.M., Walther M. Microvascular dysfunction in severe Plasmodium falciparum malaria. J Infect Dis 2013, 207:369-370.
37. Clark I.A., Alleva L.M. Is human malarial coma caused, or merely deepened, by sequestration?. Trends Parasitol 2009, 25:314-318.
38. Rubach M.P., Mukemba J., Florence S., John B., Crookston B., Lopansri B.K., et al. Plasma Plasmodium falciparum histidine-rich protein-2 concentrations are associated with malaria severity and mortality in Tanzanian children. PLoS One 2012, 7:e35985.
39. Seydel K.B., Fox L.L., Glover S.J., Reeves M.J., Pensulo P., Muiruri A., et al. Plasma concentrations of parasite histidine-rich protein 2 distinguish between retinopathy-positive and retinopathy-negative cerebral malaria in Malawian children. J Infect Dis 2012, 206:309-318.
40. Hendriksen I.C., White L.J., Veenemans J., Mtove G., Woodrow C., Amos B., et al. Defining falciparum-malaria-attributable severe febrile illness in moderate-to-high transmission settings on the basis of plasma PfHRP2 concentration. J Infect Dis 2013, 207:351-361.
41. Gravenor M.B., van Hensbroek M.B., Kwiatkowski D. Estimating sequestered parasite population dynamics in cerebral malaria. Proc Natl Acad Sci U S A 1998, 95:7620-7624.
42. Cromer D., Best S.E., Engwerda C., Haque A., Davenport M. Where have all the parasites gone? Modelling early malaria parasite sequestration dynamics. PLoS One 2013, 8:e55961.
43. Ceesay S.J., Casals-Pascual C., Nwakanma D.C., Walther M., Gomez-Escobar N., Fulford A.J., et al. Continued decline of malaria in The Gambia with implications for elimination. PLoS One 2010, 5:e12242.
44. Gravenor M.B., McLean A.R., Kwiatkowski D. The regulation of malaria parasitaemia: parameter estimates for a population model. Parasitology 1995, 110(Pt 2):115-122.
45. Bejon P., Berkley J.A., Mwangi T., Ogada E., Mwangi I., Maitland K., et al. Defining childhood severe falciparum malaria for intervention studies. PLoS Med 2007, 4:e251.
46. Berkley J.A., Bejon P., Mwangi T., Gwer S., Maitland K., Williams T.N., et al. HIV infection, malnutrition, and invasive bacterial infection among children with severe malaria. Clin Infect Dis 2009, 49:336-343.
47. Bronzan R.N., Taylor T.E., Mwenechanya J., Tembo M., Kayira K., Bwanaisa L., et al. Bacteremia in Malawian children with severe malaria: prevalence, etiology, HIV coinfection, and outcome. J Infect Dis 2007, 195:895-904.
48. Cunnington A.J., de Souza J.B., Walther M., Riley E.M. Malaria impairs resistance to Salmonella through heme- and heme oxygenase-dependent dysfunctional granulocyte mobilization. Nat Med 2011, 18:120-127.
49. Schoeps A., Gabrysch S., Niamba L., Sie A., Becher H. The effect of distance to health-care facilities on childhood mortality in rural Burkina Faso. Am J Epidemiol 2011, 173:492-498.
50. Buffet P.A., Safeukui I., Deplaine G., Brousse V., Prendki V., Thellier M., et al. The pathogenesis of Plasmodium falciparum malaria in humans: insights from splenic physiology. Blood 2011, 117:381-392.
51. Reyburn H., Mbatia R., Drakeley C., Bruce J., Carneiro I., Olomi R., et al. Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria. JAMA 2005, 293:1461-1470.
52. Warimwe G.M., Fegan G., Musyoki J.N., Newton C.R., Opiyo M., Githinji G., et al. Prognostic indicators of life-threatening malaria are associated with distinct parasite variant antigen profiles. Sci Transl Med 2012, 4:129-145.
53. Yeo T.W., Lampah D.A., Kenangalem E., Tjitra E., Price R.N., Anstey N.M. Impaired skeletal muscle microvascular function and increased skeletal muscle oxygen consumption in severe falciparum malaria. J Infect Dis 2013, 207:528-536.
54. Jallow M., Casals-Pascual C., Ackerman H., Walther B., Walther M., Pinder M., et al. Clinical features of severe malaria associated with death: a 13-year observational study in the gambia. PLoS One 2012, 7:e45645.
55. Higgins S.J., Kain K.C., Liles W.C. Immunopathogenesis of falciparum malaria: implications for adjunctive therapy in the management of severe and cerebral malaria. Expert Rev Anti Infect Ther 2011, 9:803-819.
56. Grau G.E., Craig A.G. Cerebral malaria pathogenesis: revisiting parasite and host contributions. Future Microbiol 2012, 7:291-302.
57. Cunnington A.J., Njie M., Correa S., Takem E.N., Riley E.M., Walther M. Prolonged neutrophil dysfunction after Plasmodium falciparum malaria is related to hemolysis and heme oxygenase-1 induction. J Immunol 2012, 189:5336-5346.